CN116003319A - Sulfur-containing quinoline compound and preparation method and application thereof - Google Patents

Sulfur-containing quinoline compound and preparation method and application thereof Download PDF

Info

Publication number
CN116003319A
CN116003319A CN202211532975.XA CN202211532975A CN116003319A CN 116003319 A CN116003319 A CN 116003319A CN 202211532975 A CN202211532975 A CN 202211532975A CN 116003319 A CN116003319 A CN 116003319A
Authority
CN
China
Prior art keywords
substituted
formula
fluoro
compound
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211532975.XA
Other languages
Chinese (zh)
Inventor
刘幸海
孙鑫鹏
余玮
谭成侠
翁建全
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University of Technology ZJUT
Original Assignee
Zhejiang University of Technology ZJUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University of Technology ZJUT filed Critical Zhejiang University of Technology ZJUT
Priority to CN202211532975.XA priority Critical patent/CN116003319A/en
Publication of CN116003319A publication Critical patent/CN116003319A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention discloses a sulfur-containing quinoline compound, a preparation method and application thereof, wherein the structural formula of the sulfur-containing quinoline compound is shown as the formula (I):
Figure DDA0003976557740000011
wherein H on the benzene ring is not substituted by R 1 R is R when substituted 2 Is alkyl, acetonitrile, propenyl, alkyl ester methylene, benzyl, substituted benzyl or alkoxycarbonyl, and the substituent for substituted benzyl is halogen or alkyl; h on the benzene ring being substituted, substituent R 1 In the case of tert-butyl, R 2 Is aroyl or substituted aroyl, the substituent of the substituted aroyl is alkylAn alkoxy group or a halogen. The sulfur-containing quinoline compound provided by the invention is a novel compound with good bactericidal activity, and provides a basis for researching natural green bactericides.

Description

Sulfur-containing quinoline compound and preparation method and application thereof
Technical Field
The invention belongs to the technical field of chemical synthesis and pharmaceutical application, and particularly relates to a sulfur-containing quinoline compound, and a preparation method and application thereof.
Background
Quinoline derivatives are an important class of heterocyclic aromatic compounds. In modern synthetic chemistry, quinoline compounds are widely used in a variety of fields such as coordination chemistry, organometallic chemistry, asymmetric synthesis, pharmaceutical chemistry, agrochemical chemistry, and material chemistry. The excellent antitubercular, antimalarial, bactericidal and insecticidal activities of quinoline compounds attract a plurality of scientists.
Quinoline is a structure with strong medicinal physiological activity, and the structure is easy to modify. The introduction of different drug molecules into the quinoline structure will alter or enhance its activity, which provides the basis for the synthesis of lead compounds, modification and modification of the drug structure. In conclusion, the research on quinoline compounds is long-standing.
Disclosure of Invention
The invention aims to provide a quinoline compound containing sulfur, and a preparation method and application thereof.
The invention provides a sulfur-containing quinoline compound, which has a structural formula shown in a formula (I):
Figure BDA0003976557730000011
wherein H on the benzene ring is not substituted by R 1 R is R when substituted 2 Is alkyl, acetonitrile, propenyl, alkyl ester methylene, benzyl, substituted benzyl or alkoxycarbonyl;
h on the benzene ring being substituted, R 1 In the case of tert-butyl, R 2 Is aroyl or substituted aroyl.
Preferably, the substituent for the substituted benzyl group is 2-chloro, 4-fluoro, 4-t-butyl, 4-bromo, 4-methyl, 2, 4-dichloro, 3, 4-dichloro, 2-fluoro, 3-fluoro or 4-chloro; the substituent of the substituted aroyl group is 4-tert-butyl, 2-methyl, 3-methyl, 4-methyl, 2-fluoro, 3-fluoro, 4-fluoro, 3-chloro, 4-chloro, 2, 3-dichloro, 3, 4-dichloro, 4-n-propyl, 2-methoxy or 4-methoxy.
The invention also provides a preparation method of the quinoline compound containing sulfur, which comprises the following steps of;
1) Reacting a compound shown as a formula (II) with ethyl 2-methyl acetoacetate by taking polyphosphoric acid as a cyclizing agent to generate a compound shown as a formula (III);
2) Reacting the compound shown in the formula (III) obtained in the step 1) with a Lawsen reagent by using THF as a solvent to obtain a compound shown in the formula (IV);
3) Providing an alkaline environment by using DCM or DMF as a solvent and triethylamine or sodium hydroxide, and reacting the compound shown in the formula (IV) obtained in the step 2) with a compound shown in the formula (V) to obtain quinoline compounds containing a thioester bond shown in the formula (I);
Figure BDA0003976557730000021
wherein H on the benzene ring is not substituted by R 1 R is R when substituted 2 Is alkyl, acetonitrile, propenyl, alkyl ester methylene, benzyl, substituted benzyl or alkoxycarbonyl, the substituent of the substituted benzyl is 2-chloro, 4-fluoro, 4-tert-butyl, 4-bromo, 4-methyl, 2, 4-dichloro, 3, 4-dichloro, 2-fluoro, 3-fluoro or 4-chloro;
when H on the benzene ring is substituted, R 1 In the case of tert-butyl, R 2 For aroyl or substituted aroyl, the substituent of substituted aroyl is 4-tert-butyl, 2-methyl, 3-methyl, 4-methyl, 2-fluoro, 3-fluoro, 4-fluoro, 3-chloro, 4-chloro, 2, 3-dichloro, 3, 4-dichloro, 4-n-propyl, 2-methoxy or 4-methoxy.
The reaction process is as follows:
Figure BDA0003976557730000031
wherein H on the benzene ring is not substituted by R 1 R is R when substituted 2 Is alkyl, acetonitrile, propenyl, alkyl ester methylene, benzyl, substituted benzyl or alkoxycarbonyl, the substituent of the substituted benzyl is 2-chloro, 4-fluoro, 4-tert-butyl, 4-bromo, 4-methyl, 24-dichloro, 3, 4-dichloro, 2-fluoro, 3-fluoro or 4-chloro;
h on the benzene ring being substituted, R 1 In the case of tert-butyl, R 2 For aroyl or substituted aroyl, the substituent of substituted aroyl is 4-tert-butyl, 2-methyl, 3-methyl, 4-methyl, 2-fluoro, 3-fluoro, 4-fluoro, 3-chloro, 4-chloro, 2, 3-dichloro, 3, 4-dichloro, 4-n-propyl, 2-methoxy or 4-methoxy.
Further, when the compound shown in the formula (III) is synthesized in the step 1), the mass ratio of the compound shown in the formula (II) to the substance of the 2-methyl acetoacetic acid ethyl ester is 1:1-1:1.5.
Further, when the compound shown in the formula (IV) is synthesized in the step 2), the mass ratio of the compound shown in the formula (III) to the substance of the Lawson reagent is 1:0.5-1:1.
Further, the mass ratio of the compound shown in the formula (IV) to the compound shown in the formula (V) is 1:1-1:1.5.
The invention also provides application of the sulfur-containing quinoline compound in preparation of bactericides.
The invention has the beneficial effects that:
the preparation method has simple process and no need of additional metal catalysis, and the structure of the obtained product is improved 1 H NMR and HRMS prove that the product has a certain bactericidal effect on different germs.
Detailed Description
The invention will be further illustrated with reference to specific examples, but the scope of the invention is not limited thereto.
The reaction equation is as follows:
Figure BDA0003976557730000051
examples 1-2 preparation of Compounds III-1 to III-2
Into a 250mL three-necked flask, 100.00mmol of a compound represented by formula (II) (wherein H on the benzene ring is substituted by R 1 Substituted or unsubstituted, R being the substituent 1 Is tert-butyl)Ethyl 2-methylacetoacetate (14.42 g,100.00 mmol), polyphosphoric acid (50.69 g,150.00 mmol), and TLC (V) EA /V PE =1/1) tracking the reaction progress, stopping the reaction after 5 hours, cooling to room temperature, putting the reaction bottle into an ice bath, adjusting the pH to 7 by using a sodium hydroxide aqueous solution with the mass concentration of 10%, precipitating a large amount of solids, carrying out suction filtration, taking a filter cake, and drying to obtain the compounds III-1 to III-2.
Examples 3-4 preparation of Compounds IV-1 to IV-2
Into a 100mL three-necked flask, 30.00mmol of a compound represented by the formula (III) wherein H on the benzene ring is substituted with the substituent R 1 Substituted or unsubstituted, R being the substituent 1 Tert-butyl) and Lawson's reagent (8.09 g,20.00 mmol), and THF (30 mL) was added, heated to reflux, TLC (V) EA /V PE =1/1) the progress of the reaction was followed, after the end of the reaction, the solvent was dried by spinning, the residue was dissolved in ethyl acetate solution and transferred to a separatory funnel, and saturated NaHCO was used 3 Washing the solution (20 mL multiplied by 3), drying by anhydrous sodium sulfate, filtering, spin-drying the solvent, and purifying by column chromatography to obtain the compounds IV-1 to IV-2.
EXAMPLES 5-20 preparation of Compounds I-1 to I-16
A50 mL round-bottomed flask was charged with the compound represented by the formula (IV) (0.20 g,0.96 mmol), sodium hydroxide (0.05 g,1.25 mmol) and DMF (5 mL) in this order, and after stirring at room temperature for half an hour, 1.01mmol of the compound represented by the formula (V) (corresponding substituent R) 1 And R is 2 Stirring was continued as shown in Table 1, TLC (V) EA /V PE =1/4), after the reaction, transferring to a separating funnel, adding water (15 mL), extracting with ethyl acetate (5 ml×3), mixing the organic phases, washing with saturated saline (5 ml×3), drying with anhydrous sodium sulfate, filtering, spin-drying the solvent, and purifying by column chromatography to obtain the target compounds I-1 to I-16.
Examples 21-39 preparation of Compounds I-17 to I-35
A50 mL round-bottomed flask was charged with the compound represented by the formula (IV) (0.96 mmol), triethylamine (0.5 mmol) and DCM (5 mL) in this order, and after stirring at room temperature for half an hour, the compound represented by the formula (V) was added(1.06 mmol) (corresponding substituent R 1 And R is 2 Stirring was continued as shown in Table 1, TLC (V) EA /V PE =1/4), after the reaction, transferring to a separating funnel, adding water (15 mL), extracting with ethyl acetate (5 ml×3), mixing the organic phases, washing with saturated saline (5 ml×3), drying with anhydrous sodium sulfate, filtering, spin-drying the solvent, and purifying by column chromatography to obtain the target compounds I-17 to I-35.
TABLE 1 physical Properties of quinoline Compounds containing Sulfur
Figure BDA0003976557730000061
/>
Figure BDA0003976557730000071
/>
Figure BDA0003976557730000081
TABLE 2 characterization data for quinoline Compounds containing Sulfur
Figure BDA0003976557730000082
/>
Figure BDA0003976557730000091
/>
Figure BDA0003976557730000101
/>
Figure BDA0003976557730000111
/>
Figure BDA0003976557730000121
/>
Figure BDA0003976557730000131
/>
Figure BDA0003976557730000141
/>
Figure BDA0003976557730000151
/>
Figure BDA0003976557730000161
/>
Figure BDA0003976557730000171
/>
Figure BDA0003976557730000181
EXAMPLE 40 bactericidal Activity test
Test method
(1) Test object: tomato early blight (Alternaria solani), wheat scab (Gibberella zeae), rice blast (Pyricularia oryae), pepper phytophthora capsici (Phytophthora capsici), sclerotinia sclerotiorum (Sclerotinia sclerotiorum), cucumber Botrytis cinerea (Botrytis cinerea), rhizoctonia solani (Riziocotinia solani), cucumber fusarium wilt (Fusarium oxysporum), peanut brown spot (Cercospora arachidicola) and apple ring rot (Botryosphaeria berengriana)
(2) Test treatment: each test compound was dissolved in DMSO to 1% EC mother liquor for use. The indoor bactericidal activity of the compound to be tested on the test target at the dose of 50ppm is evaluated by adopting a bacteriostasis circle method, and a water control (QCK) is additionally arranged.
(3) The test method comprises the following steps: 150. Mu.l of the EC mother solution thus prepared was sucked by a pipette and dissolved in 2.85mL of warm water to prepare a drug solution having an effective concentration of 500ppm of the compound to be tested. 1ml of the liquid medicine is sucked by a pipette, placed in a sterilized culture dish, placed in 9ml of PDA culture medium, shaken uniformly and cooled. After taking out the circular bacterial cake by a puncher, picking up the circular bacterial cake to the center of a culture dish by an inoculating needle, then placing the culture dish in an incubator at 27 ℃ for culturing, and measuring the colony diameter after 48 hours. The pure growth of the bacterial colony is the difference value between the average diameter of the bacterial colony and the diameter of a bacterial cake, and the calculation method of the bacteriostasis rate (%) refers to the following formula.
Figure BDA0003976557730000191
The activity test results are shown in table 3:
TABLE 3 bactericidal activity of quinoline containing sulfur
Figure BDA0003976557730000192
/>
Figure BDA0003976557730000201
/>
Figure BDA0003976557730000211
The results of the bactericidal activity of 35 quinoline compounds containing sulfur show that (table 3) under the concentration of 50ppm, the compound I-12 has good bactericidal activity, the bactericidal activity for wheat scab is 75.0%, and the bactericidal activity for two germs of sclerotium and apple ring rot are 88.5% and 81.2%, respectively. In addition, the bactericidal activity of the compound I-12 on tomato early blight bacteria, pepper phytophthora capsici and cucumber fusarium wilt bacteria respectively reaches 56.3%, 58.1% and 55.0%.
What has been described in this specification is merely an enumeration of possible forms of implementation for the inventive concept, and the scope of protection of the present invention should not be construed as limited to the specific forms set forth in the examples, nor is it intended that the scope of protection of the present invention be limited to only equivalent technical means as would occur to those skilled in the art based on the inventive concept.

Claims (7)

1. A sulfur-containing quinoline compound is characterized in that the structural formula is shown as a formula (I):
Figure FDA0003976557720000011
wherein H on the benzene ring is not substituted by R 1 R is R when substituted 2 Is alkyl, acetonitrile, propenyl, alkyl ester methylene, benzyl, substituted benzyl or alkoxycarbonyl, and the substituent for substituted benzyl is halogen or alkyl;
h on the benzene ring being substituted, substituent R 1 In the case of tert-butyl, R 2 Is aroyl or substituted aroyl, and the substituent of the substituted aroyl is alkyl, alkoxy or halogen.
2. A sulfur-containing quinoline compound according to claim 1 wherein the substituent substituted for the benzyl group is 2-chloro, 4-fluoro, 4-t-butyl, 4-bromo, 4-methyl, 2, 4-dichloro, 3, 4-dichloro, 2-fluoro, 3-fluoro or 4-chloro; the substituent of the substituted aroyl group is 4-tert-butyl, 2-methyl, 3-methyl, 4-methyl, 2-fluoro, 3-fluoro, 4-fluoro, 3-chloro, 4-chloro, 2, 3-dichloro, 3, 4-dichloro, 4-n-propyl, 2-methoxy or 4-methoxy.
3. A process for the preparation of a sulfur-containing quinoline compound according to claim 2, comprising the steps of:
1) Reacting a compound shown as a formula (II) with ethyl 2-methyl acetoacetate by taking polyphosphoric acid as a cyclizing agent to generate a compound shown as a formula (III);
2) Reacting the compound shown in the formula (III) obtained in the step 1) with a Lawsen reagent by using THF as a solvent to obtain a compound shown in the formula (IV);
3) Providing an alkaline environment by using DCM or DMF as a solvent and triethylamine or sodium hydroxide, and reacting the compound shown in the formula (IV) obtained in the step 2) with a compound shown in the formula (V) to obtain quinoline compounds containing a thioester bond shown in the formula (I);
Figure FDA0003976557720000021
wherein H on the benzene ring is not substituted by R 1 R is R when substituted 2 Is alkyl, acetonitrile, propenyl, alkyl ester methylene, benzyl, substituted benzyl or alkoxycarbonyl, the substituent of the substituted benzyl is 2-chloro, 4-fluoro, 4-tert-butyl, 4-bromo, 4-methyl, 2, 4-dichloro, 3, 4-dichloro, 2-fluoro, 3-fluoro or 4-chloro;
when H on the benzene ring is substituted, R 1 In the case of tert-butyl, R 2 For aroyl or substituted aroyl, the substituent of substituted aroyl is 4-tert-butyl, 2-methyl, 3-methyl, 4-methyl, 2-fluoro, 3-fluoro, 4-fluoro, 3-chloro, 4-chloro, 2, 3-dichloro, 3, 4-dichloro, 4-n-propyl, 2-methoxy or 4-methoxy.
4. The process according to claim 3, wherein the amount ratio of the compound represented by the formula (II) to the ethyl 2-methylacetoacetate is 1:1 to 1:1.5 in the synthesis of the compound represented by the formula (III) in the step 1).
5. The process according to claim 3, wherein the mass ratio of the compound represented by the formula (III) to the Lawsen agent is 1:0.5 to 1:1 when the compound represented by the formula (IV) is synthesized in the step 2).
6. The process according to claim 3, wherein the ratio of the compound of the formula (IV) to the compound of the formula (V) is 1:1 to 1:1.5.
7. Use of a sulfur-containing quinoline compound according to claim 1 or 2 for the preparation of a fungicide.
CN202211532975.XA 2022-12-02 2022-12-02 Sulfur-containing quinoline compound and preparation method and application thereof Pending CN116003319A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211532975.XA CN116003319A (en) 2022-12-02 2022-12-02 Sulfur-containing quinoline compound and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211532975.XA CN116003319A (en) 2022-12-02 2022-12-02 Sulfur-containing quinoline compound and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN116003319A true CN116003319A (en) 2023-04-25

Family

ID=86027330

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211532975.XA Pending CN116003319A (en) 2022-12-02 2022-12-02 Sulfur-containing quinoline compound and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN116003319A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1034924A (en) * 1988-01-29 1989-08-23 伊莱利利公司 quinoline, quinazoline and cinnoline derivatives
JPH0641117A (en) * 1992-07-24 1994-02-15 Mitsui Toatsu Chem Inc Pyrimidinylthioquinoline derivative, its production and agricultural and horticultural fungicide containing the derivative as active component
CN115124463A (en) * 2022-07-01 2022-09-30 浙江工业大学 Substituted quinoline compound and preparation method and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1034924A (en) * 1988-01-29 1989-08-23 伊莱利利公司 quinoline, quinazoline and cinnoline derivatives
JPH0641117A (en) * 1992-07-24 1994-02-15 Mitsui Toatsu Chem Inc Pyrimidinylthioquinoline derivative, its production and agricultural and horticultural fungicide containing the derivative as active component
CN115124463A (en) * 2022-07-01 2022-09-30 浙江工业大学 Substituted quinoline compound and preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
唐除痴: "《有机合成中的有机磷试剂》", 30 November 1992, 南开大学出版社, pages: 16 *

Similar Documents

Publication Publication Date Title
CN112062759B (en) Ethylsulfonyl-containing pyridine-1, 2, 4-oxadiazole substituted benzamide compounds and preparation method and application thereof
CN115124463B (en) Substituted quinoline compound and preparation method and application thereof
WO2015000392A1 (en) N-(aryl alkyl) aryloxy phenoxy carboxylic acid amide compound and preparation method and application thereof
CN105601575B (en) With antibacterial activity quinoxalines-N1,N4Dioxide derivative
CN116003319A (en) Sulfur-containing quinoline compound and preparation method and application thereof
CN114276287B (en) N- (substituted benzyloxy) amide compound and preparation method and application thereof
CN105111192B (en) Triazole Mannich base class compound and its preparation and application containing trifluoromethyl and piperazine
CN114213311B (en) Substituted benzaldehyde oxime ester compound and preparation method and application thereof
CN114957116A (en) 2, 3-dimethyl-8-fluoroquinoline-4-ester compound and preparation method and application thereof
CN110615764A (en) N- (2-benzamide) -1H-pyrazole-4-formamide compound and preparation method and application thereof
CN115124462B (en) 2, 3-dimethyl-6, 8-difluoro quinoline-4-ether compound and preparation method and application thereof
CN113563281B (en) Benzophenone compound containing 1,3, 4-thiadiazole thioether structure and application thereof
CN115925680B (en) Trifluoromethyl-containing pyridine compound and preparation method and application thereof
CN115141142B (en) 2, 3-dimethyl-8-fluoroquinoline-4-ether compound and application thereof
CN115784984A (en) Quinoline compound containing ester bond and preparation method and application thereof
CN115772122A (en) Benzamide compound and preparation method and application thereof
CN114957124B (en) 3- (trifluoromethyl) -pyrazole-4-carboxylic ester derivative and preparation method and application thereof
CN107056687B (en) Pyridine group-containing 1, 4-pentadiene-3-ketoxime ester compound, preparation method and application
CN114957123B (en) 3- (difluoromethyl) -pyrazole-4-carboxylic ester derivative and preparation method and application thereof
CN117720460A (en) Quinoline compound and preparation method and application thereof
CN110669007A (en) 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic ester compound and preparation method and application thereof
CN116178263B (en) Nitro-containing pyrazole carboxamide compound as well as preparation method and application thereof
CN117720461A (en) Ketone compound taking quinoline ring as framework, and preparation method and application thereof
CN110463704B (en) Application of 1-adamantane carboxylic acid-2- (substituted benzoyl oxy) ethyl ester compound as bactericide
CN116082324A (en) Heterocyclic 1,2, 4-oxadiazole compound, and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination